Baidu
map

Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials

Long, T; Lin, JT; Lin, MH; Wu, QL; Lai, JM; Li, SZ; Zhou, ZC; Zeng, JY; Huang, JS; Zeng, CP; Lai, YM

Zeng, CP (通讯作者),Guangzhou Med Univ, Dept Endocrinol, Affiliated Hosp 5, 621 Gangwan Rd, Guangzhou 510700, Peoples R China.;Lai, YM (通讯作者),Guangzhou Med Univ, Affiliated Hosp 5, Dept Rehabil Med, 621 Gangwan Rd, Guangzhou 510700, Peoples R China.

ENDOCRINE JOURNAL, 2022; 69 (8): 959

Abstract

Recent studies have found compared with insulin glargine (IGlar), insulin degludec/aspart (IDegAsp) may provide adequate glycemic control and prevent ......

Full Text Link


Baidu
map
Baidu
map
Baidu
map